Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 19, 2022, Nephros, Inc. (the "Company") held its 2022 Annual Meeting of the Stockholders (the "Annual Meeting"). At the Annual Meeting:

1. Stockholders elected to the Company's Board of Directors two nominees, Andrew

Astor and Alisa Lask, to each serve a three-year term expiring in 2025;

2. Stockholders ratified the appointment of Baker Tilly US, LLP as the Company's

independent registered public accounting firm for the fiscal year ending

December 31, 2022; and

3. Stockholders approved the compensation of the Company's named executive


    officers on an advisory (non-binding) basis.

The voting results for each such matter were as follows:





 1. Election of Directors:




Nominee:          For:         Withheld:       Broker Non-Votes:
Andrew Astor     6,189,006        134,108               2,333,049
Alisa Lask       6,192,377        130,737               2,333,049

2. Ratification of the appointment of Baker Tilly US, LLP as the Company's

independent registered public accounting firm for the fiscal year ending

December 31, 2022:




   For:         Against:       Abstain:      Broker Non-Votes
  8,637,438        17,548          1,177                     0

3. Approval of the compensation of the Company's named executive officers on an

advisory (non-binding) basis:






   For:         Against:      Abstain:       Broker Non-Votes
  6,093,819       216,653        12,642              2,333,049

© Edgar Online, source Glimpses